Literature DB >> 11853157

Gastrointestinal transit and drug absorption.

Toshikiro Kimura1, Kazutaka Higaki.   

Abstract

The gastrointestinal (GI) absorption of orally administered drugs is determined by not only the permeability of GI mucosa but also the transit rate in the GI tract. It is well known that the gastric emptying rate is an important factor affecting the plasma concentration profile of orally administered drugs, and the intestinal transit rate also has a significant influence on the drug absorption, since it determines the residence time of the drug in the absorption site. The reason why the residence time is also a critical factor for drug absorption is that there is the site difference in absorbability for some drugs. We have developed the GI-Transit-Absorption Model (GITA Model) to analyze and predict the drug absorption kinetics by taking into account both the two factors, ie. GI transit and drug absorbability including its site difference. GITA Model has been already evidenced to be very useful for estimating the absorption kinetics of drugs with various characteristics and applied to assess the human data in combination with the gamma scintigraphy. In this review, the importance of GI transit rate in determining the absorption kinetics and the bioavailability of orally administered drugs is discussed mainly employing GITA Model and the results obtained by the model.

Entities:  

Mesh:

Year:  2002        PMID: 11853157     DOI: 10.1248/bpb.25.149

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  30 in total

1.  Effect of cutaneous blood flow on absorption of insulin: a methodological study in healthy male volunteers.

Authors:  Lydia A Jakobsen; Anne Jensen; Lars E Larsen; Morten R Sørensen; Hans Christian Hoeck; Lars Arendt-Nielsen; Parisa Gazerani
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2011-11-15

2.  Effect of local controlled heat on transdermal delivery of nicotine.

Authors:  Kristian Kjær Petersen; Mark Lillelund Rousing; Carina Jensen; Lars Arendt-Nielsen; Parisa Gazerani
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2011-09-08

Review 3.  Biomagnetic methods: technologies applied to pharmaceutical research.

Authors:  Luciana A Corá; Madileine F Américo; Ricardo B Oliveira; Cristina H R Serra; Oswaldo Baffa; Raul C Evangelista; Giselle F Oliveira; José Ricardo Aruda Miranda
Journal:  Pharm Res       Date:  2010-10-15       Impact factor: 4.200

4.  Continuous Intestinal Absorption Model Based on the Convection-Diffusion Equation.

Authors:  Swati Nagar; Richard C Korzekwa; Ken Korzekwa
Journal:  Mol Pharm       Date:  2017-07-31       Impact factor: 4.939

Review 5.  Mechanistic approaches to predicting oral drug absorption.

Authors:  Weili Huang; Sau Lawrence Lee; Lawrence X Yu
Journal:  AAPS J       Date:  2009-04-21       Impact factor: 4.009

6.  Quantitative evaluation of PEPT1 contribution to oral absorption of cephalexin in rats.

Authors:  Takanori Hironaka; Shota Itokawa; Ken-ichi Ogawara; Kazutaka Higaki; Toshikiro Kimura
Journal:  Pharm Res       Date:  2008-09-11       Impact factor: 4.200

7.  Intestinal permeability of metformin using single-pass intestinal perfusion in rats.

Authors:  Nai-Ning Song; Quan-Sheng Li; Chang-Xiao Liu
Journal:  World J Gastroenterol       Date:  2006-07-07       Impact factor: 5.742

8.  Effect of dose escalation on the in vivo oral absorption and disposition of glycylsarcosine in wild-type and Pept1 knockout mice.

Authors:  Dilara Jappar; Yongjun Hu; David E Smith
Journal:  Drug Metab Dispos       Date:  2011-08-31       Impact factor: 3.922

9.  Appearance of double peaks in plasma concentration-time profile after oral administration depends on gastric emptying profile and weight function.

Authors:  Yukiko Metsugi; Yoshihiro Miyaji; Ken-ichi Ogawara; Kazutaka Higaki; Toshikiro Kimura
Journal:  Pharm Res       Date:  2007-10-23       Impact factor: 4.200

10.  Pharmacokinetic modeling of absorption behavior of 9-aminocamptothecin (9-AC) released from colon-specific HPMA copolymer-9-AC conjugate in rats.

Authors:  Song-Qi Gao; Yongen Sun; Pavla Kopecková; C Matthew Peterson; Jindrich Kopecek
Journal:  Pharm Res       Date:  2007-10-11       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.